166 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron’s Products and Regeneron's Product Candidates
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
of Regeneron’s collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling
8-K
EX-99.1
vxgfx
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
kgq0ikomwt tyk
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T/A
EX-99
pza0th
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T
EX-99
xmd brtactlf
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
zuuaip9571r5l 8rbf8i
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.1
7e05qv 25o
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.2
uqu7pd3bg1nlisfwt0k
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
e5a79 ear
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
PX14A6G
1q5f9sfg
18 May 23
Letter to shareholders
4:46pm
8-K
EX-99.1
iw4x3kb
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am